Reducing Neutropenia Incidence With Pegfilgrastim Administration on Day 3 After Chemotherapy
Clinical trial NCT05949333 · UNKNOWN
Trial details
- NCT number
- NCT05949333
- Sponsor
- Eunseong Medical Foundation Good GANG-AN HOSPITAL
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-07
- Primary completion
- 2025-01-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.